BioVascular, Inc.

BioVascular, Inc.

BioVascular, Inc.

Date Founded



12230 El Camino Real,Suite 100,San Diego, CA 92130

Type of Company




Company Description

BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA.

Executives & Employees



Chief Medical Officer & Vice President of Clinical Research & Regulatory Affairs

Vice President-Pharmaceutical Operations

Board of Directors

Partner at Domain Associates LLC

Managing Director at BB Biotech Ventures

Former Board Member & Director at Vaximm AG

Co-Founder at BioVascular, Inc.

Co-Founder at BioVascular, Inc.

Former Chairman, Department of Biomedical Engineering at Oregon Health and Sciences University - School of Medicine

Paths to BioVascular, Inc.
Potential Connections via
Relationship Science
BioVascular, Inc.
Recent Transactions
Details Hidden

Domain Associates LLC, BioVascular, Inc. purchase Revitus, Inc.

Transaction Advisors
Legal Advisor

Advised onDomain Associates LLC, BioVascular, Inc. purchase Revitus, Inc.

Details Hidden

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Details Hidden

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.

Details Hidden

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by BioVascular, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of BioVascular, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and BioVascular, Inc..